Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Advair HFA (Fluticasone Propionate and Salmeterol Xinafoate) Inhalation Aerosol
Company:  GlaxoSmithKline
Application No.:  021254
Approval Date: 06/08/2006


Date created: May 6, 2008

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.